Best Peptides for Inflammaging

Inflammaging refers to chronic, systemic low-grade inflammation that develops with age, driven by accumulation of senescent cells, immune dysregulation, and persistent antigenic stimulation. Research peptides are being investigated for their potential to modulate immune function, reduce pro-inflammatory cytokine production, and support cellular clearance mechanisms. While no single peptide has emerged as a primary therapeutic target for inflammaging, compounds like senolytics and immunomodulatory peptides are under study to understand how peptide-based interventions might slow age-related inflammatory processes.

Research on peptides for inflammaging typically employs protocols ranging from low-dose chronic administration to cyclical dosing regimens, with timing often coordinated to circadian immune patterns. Most investigational approaches prioritize consistency and extended duration over high acute doses, reflecting the chronic nature of the condition.